Scarica l'app Stockscreener
2.461
2.97%
0.071
Precedente Chiudi:
$2.39
Aprire:
$2.39
Volume 24 ore:
46,484
Relative Volume:
0.09
Capitalizzazione di mercato:
$148.10M
Reddito:
-
Utile/perdita netta:
$-64.86M
Rapporto P/E:
-2.1973
EPS:
-1.12
Flusso di cassa netto:
$-55.66M
1 W Prestazione:
+2.54%
1M Prestazione:
+42.25%
6M Prestazione:
+93.78%
1 anno Prestazione:
+68.56%
Intervallo 1D:
$2.385
$2.47
Intervallo di 1 settimana:
$2.2501
$2.58
Portata 52W:
$0.8551
$3.0499
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
Nome
Acumen Pharmaceuticals Inc
Settore
Industria
Telefono
617-344-4190
Indirizzo
1210-1220 WASHINGTON STREET, NEWTON
Compare ABOS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
2.445 | 144.77M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
487.64 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
797.01 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
845.76 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.60 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
350.38 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | Citigroup | Buy |
| 2024-07-26 | Iniziato | Citigroup | Buy |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-07-20 | Ripresa | BofA Securities | Buy |
| 2023-05-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-07-15 | Iniziato | BTIG Research | Buy |
| 2022-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-07-26 | Iniziato | BofA Securities | Neutral |
| 2021-07-26 | Iniziato | Credit Suisse | Outperform |
| 2021-07-26 | Iniziato | Stifel | Buy |
| 2021-07-26 | Iniziato | UBS | Buy |
Mostra tutto
Acumen Pharmaceuticals Inc Borsa (ABOS) Ultime notizie
Acumen Pharmaceuticals celebrates team contributions - Traders Union
Brokerages Set Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Price Target at $6.80 - Defense World
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS) - The Globe and Mail
Acumen Pharmaceuticals (NASDAQ:ABOS) Rating Lowered to Sell at Wall Street Zen - MarketBeat
While Institutions Invested in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Benefited From Last Week's 46% Gain, Private Equity Firms Stood to Gain the Most - 富途牛牛
Acumen Pharma CLO sells $53k in shares after option exercise - Investing.com Canada
Healthcare Stocks Surge in After-Hours Trading - intellectia.ai
Wall Street Analysts Adjust Ratings - intellectia.ai
Assessing Acumen Pharmaceuticals (ABOS) Valuation After New Phase 2 ALTITUDE-AD Trial Developments - Yahoo Finance
Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target Raised to $7.00 at BTIG Research - MarketBeat
Are Insider Tax-Related Sales Misaligned With Acumen Pharmaceuticals’ (ABOS) Alzheimer’s Trial Progress Narrative? - Sahm
Baker Hughes To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
ABOS: BTIG Raises Price Target to $7.00, Maintains Buy Rating | - GuruFocus
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Acumen Pharmaceuticals’ Share Volatility: Insight Into Recent Developments - StocksToTrade
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Does Sabirnetug’s Phase 2 Extension and Insider Stock Sales Alter the Bull Case for ABOS? - Yahoo Finance
Acumen Pharmaceuticals CEO sells shares worth $21993 By Investing.com - Investing.com Nigeria
Acumen Pharmaceuticals CLO sells shares worth $16,720 By Investing.com - Investing.com South Africa
Acumen Pharma CFO Zuga sells shares worth $7.6k By Investing.com - Investing.com Canada
Acumen Pharmaceuticals CEO sells shares worth $21993 - Investing.com
Daniel Joseph Oconnell Sells 9,346 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Acumen Pharmaceuticals CLO sells shares worth $16,720 - Investing.com
Acumen Pharma CMO Siemers sells $5.8k in ABOS stock By Investing.com - Investing.com UK
"Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials - Clinical Leader
January 2026's Rising Stars: Top Penny Stocks To Watch - simplywall.st
VIX Spike: How does Acumen Pharmaceuticals Inc perform in inflationary periods2025 Technical Overview & Smart Swing Trading Techniques - baoquankhu1.vn
EV Market: What is the earnings history of Acumen Pharmaceuticals IncQuarterly Performance Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn
Acumen Pharmaceuticals Inc. (ABOS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Daniel Joseph Oconnell Sells 12,941 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - Defense World
Meisner, Acumen Pharmaceuticals CLO, sells $91k in ABOS stock By Investing.com - Investing.com UK
Acumen Pharma CEO O’Connell sells $47k in shares By Investing.com - Investing.com Canada
Acumen Pharma COO Barton sells $6.5k in shares By Investing.com - Investing.com Canada
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 12,941 Shares - MarketBeat
Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Sells $14,820.26 in Stock - MarketBeat
Insider Selling: Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Sells 6,888 Shares of Stock - MarketBeat
Meisner, Acumen Pharmaceuticals CLO, sells $91k in ABOS stock - Investing.com
Acumen Pharmaceuticals, Inc Updates Corporate Presentation with New Data - TradingView
Acumen Pharmaceuticals (NASDAQ:ABOS) Insider Sells $11,769.94 in Stock - Defense World
Acumen Pharmaceuticals COO Barton Russell sells shares worth $4,692 - MSN
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Acumen Pharmaceuticals CFO sells shares totaling $56,619 - MSN
Acumen pharma chief regulatory officer sells $2k in shares By Investing.com - Investing.com UK
Acumen Pharma president Doherty sells $15k in ABOS stock By Investing.com - Investing.com Nigeria
Acumen Pharma president Doherty sells $15k in ABOS stock - Investing.com
Acumen pharma chief regulatory officer sells $2k in shares - Investing.com
James Doherty Sells 6,467 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock - MarketBeat
Will Acumen Pharmaceuticals Inc. stock outperform international peers2025 Trading Volume Trends & Breakout Confirmation Alerts - ulpravda.ru
Can Acumen Pharmaceuticals Inc. stock beat market expectations this quarterQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - ulpravda.ru
Acumen Pharmaceuticals Inc Azioni (ABOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Acumen Pharmaceuticals Inc Azioni (ABOS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 28 '26 |
Option Exercise |
1.85 |
2,671 |
4,941 |
176,670 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 26 '26 |
Sale |
3.00 |
15,085 |
45,263 |
173,999 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 28 '26 |
Sale |
3.00 |
2,671 |
8,017 |
173,999 |
0.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):